ID   ECMA-1
AC   CVCL_A1QK
SY   P1-CL; CL1
DR   cancercelllines; CVCL_A1QK
DR   GEO; GSM4563055
DR   Wikidata; Q102114699
RX   PubMed=33087752;
CC   Population: Caucasian.
CC   Doubling time: 87 hours (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Heterozygous (PubMed=33087752).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=33087752
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 15,16
ST   D16S539: 11,12.1
ST   D5S818: 13
ST   D7S820: 9.2,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
RX   PubMed=33087752; DOI=10.1038/s41598-020-74797-0; PMCID=PMC7578805;
RA   Hirsch D., Seyfried S., Staib T., Fiedler D., Sauer C., Ried T.,
RA   Witt S., Rueckert F., Gaiser T.;
RT   "Newly established gastrointestinal cancer cell lines retain the
RT   genomic and immunophenotypic landscape of their parental cancers.";
RL   Sci. Rep. 10:17895.1-17895.11(2020).
//